Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-γ antibodies alters trypanosome-susceptible mice to a resistant- like phenotype

Journal of Immunology

Volumn 161, Issue 10, 1998, Pages 5507-5515

  Uzonna, Jude E ^a   Kaushik, Radhey S ^a   Gordon, John R ^a   Tabel, Henry ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CONCANAVALIN A; DIMINAZENE ACETURATE; GAMMA INTERFERON; INTERFERON ANTIBODY; INTERLEUKIN 4; MESSENGER RNA; N(G) METHYLARGININE; NEUTRALIZING ANTIBODY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

AFRICAN TRYPANOSOMIASIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; INFECTION RESISTANCE; INTERFERON PRODUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PARASITEMIA; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; SURVIVAL TIME; TRYPANOSOMA CONGOLENSE;

ANIMALS; ANTIBODIES, MONOCLONAL; CONCANAVALIN A; FEMALE; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, NATURAL; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PARASITEMIA; PHENOTYPE; RNA, MESSENGER; SPLEEN; TRYPANOSOMA CONGOLENSE; TRYPANOSOMIASIS, AFRICAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032533851     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Gray, A. R., and A. G. Luckins. 1976. Antigenic variation in salivarian trypanosomes. In Biology of the Kinetoplastida, Vol. 1. W. H. R. Lumsden and D. A. Evans, eds. Academic Press, London, p. 493.
2. Barry, J. D., and C. M. R. Turner. 1991. The dynamics of antigenic variation and growth of African trypanosomes. Parasitol. Today 7:207.
3. Barry, J. D. 1997. The biology of antigenic variation in African trypanosomes. In Trypanosomiasis and Leishmaniasis: Biology and Control. G. Hide, J. C. Mottram, G. H. Coombs, and P. H. Holmes, eds. CAB International Wallingford, Great Britain, p. 89.
4. Askonas, B. A. 1985. Macrophages as mediators of immunosuppression in African trypanosomiasis. Curr. Top. Microbiol. 117:119.
5. Darji, A., R. Lucas, S. Magez, E. Torreele, J. Palacios, M. Sileghem, E. Bajyana-Songa, R. Hammers, and P. De Baetselier. 1992. Mechanisms underlying trypanosome-elicited immunosuppression. Ann. Soc. Belg. Med. Trop. 72 (Suppl. 1):27.
6. Sileghem, M., J. N. Flynn, A. Darji, P. De Baetselier, and J. Naessens. 1994. African trypanosomiasis. In Parasitic Infections and the Immune System. F. Kierszenbaum, ed. Academic Press, New York, p. 1.
7. Taylor, K. A. 1998. Immune responses of cattle to African trypanosomes: protective or pathogenic? Int. J. Parasitol. 28:219.
8. Greenwood, B. M., H. C. Whittle, and D. H. Molyneux. 1973. Immunosuppression in Gambian trypanosomiasis. Trans. R. Soc. Trop. Med. Hyg. 67:846.
9. Murray, M., W. I. Morrison, and D. D. Whitelaw. 1982. Host susceptibility to African trypanosomiasis. Adv. Parasitol. 1:1.
10. Mansfield, J. M. 1990. Immunology of African trypanosomiasis, In Modern Parasite Biology: Cellular, Immunological, and Molecular Aspects. D. J. Wyler, ed. W. H. Freeman and Company, New York, p. 222.
11. Pinder, M., P. Chassin, and F. Fumoux. 1986. Mechanisms of self cure in Trypanosoma congolense infection in mice. J. Immunol. 136:1427.
12. Otesile, E. B., M. Lee, and H. Tabel. 1991. Plasma levels of proteins of the alternative complement pathway in inbred mice that differ in resistance to Trypanosoma congolense infections. J. Parasitol. 77:958.
13. Ogunremi, O., and H. Tabel. 1995. Genetics of resistance to Trypanosoma congolense in inbred mice: efficiency of apparent clearance of parasites correlates with long-term survival. J. Parasitol. 81:876.
14. Levine, R. F., and J. M. Mansfield. 1984. Genetics of resistance to the African trypanosomes. III. Variant specific antibody response of H-2 compatible resistance and susceptible mice. J. Immunol. 133:1564.
15. Sher, A., and R. L. Coffman. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385.
16. Bancroft, G. J., C. J. Sutton, A. J. Morris, and B. Askonas. 1983. Production of interferons during experimental African trypanosomiasis. Clin. Exp. Immunol. 52:135.
17. Schleifer, K. W., and J. M. Mansfield. 1993. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J. Immunol. 151:5492.
18. Sternberg, J., and F. McGuigan. 1992. Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection. Eur. J. Immunol. 22:2741.
19. Darji, A., A. Beschin, M. Sileghem, H. Heremans, L. Brys, and P. De Baetselier. 1996. In vitro simulation of immunosuppression caused by Trypanosoma brucei: active involvement of endogenous γ interferon and tumor necrosis factor in the pathway of suppression. Infect. Immun. 64:1937.
20. + T cells: a trypanosome released factor triggers interferon-γ production that stimulates parasite growth. Eur. J. Immunol. 21:2447.
21. De Ghee, A. L., G. Sonnenfeld, and J. M. Mansfield. 1985. Genetics of resistance to African trypanosomes. V. Qualitative and quantitative differences in interferon γ production among susceptible and resistant mouse strains. J. Immunol. 134: 2723.
22. Magez, S., R. Lucas, A. Darji, E. B. Songa, R. Hamers, and P. De Baetselier. 1993. Murine tumor necrosis factor plays a protective role during the initial phase of the experimental infection with Trypanosoma brucei brucei. Parasite Immunol. 15:635.
23. Lucas, R., S. Magez, R. De Leys, L. Fransen, J. P. Scheerlinck, M. Rampelberg, E. Sablon, and P. De Baetselier. 1994. Mapping the lectin-like activity of tumor necrosis factor. Science 263:814.
24. Magez, S., M. Geuskens, A. Beschin, H. del Favero, H. Verchueren, R. Lucas, E. Pays, and P. De Baetselier. 1997. Specific uptake of tumor necrosis factor-α is involved in growth control of Trypanosoma brucei. J. Cell Biol. 137:715.
25. Bakhiet, M., L. Jansson, P. Buscher, R. Holmdahl, K. Kristensson, and T. Olsson. 1996. Control of parasitemia and survival during Trypanosoma brucei brucei infection is related to strain-dependent ability to produce IL-4. J. Immunol. 157: 3518.
26. Uzonna, J. E., R. S. Kaushik, J. R. Gordon, and H. Tabel. 1998. Immunoregulation in experimental murine Trypanosoma congolense infection: anti-lL-10 antibodies reverse trypanosome-mediated suppression of lymphocyte proliferation in vitro and moderately but significantly prolong the lifespan of genetically susceptible BALB/c mice. Parasite Immunol. 20:293.
27. Tabel, H. 1982. Activation of the alternative pathway of bovine complement by Trypanosoma congolense. Parasite Immunol. 4:29.
28. Lanham, S. M., and D. G. Godfrey. 1970. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp. Parasitol. 28:521.
29. Herbert, W. J., and W. H. R. Lumsden. 1976. Trypanosoma brucei: a rapid "matching method" for estimating parasitemia. Exp. Parasitol. 40:427.
30. Mosmann, T. R. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55.
31. Familletti, P. C., S. Rubinstein, and S. Pestka. 1981. A convenient and rapid cytopathic effect inhibition assay for interferon. Methods Enzymol. 78:387.
32. Green, L. M., J. L. Reade, and C. F. Ware. 1984. Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J. Immunol. Methods 70:257.
33. Moncada, S., R. M. J. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109.
34. 15N]nitrate in biological fluids. Anal. Biochem. 126:131.
35. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.
36. Candolfi, C., C. A. Hunter, and J. S. Remington. 1995. Roles of γ interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and Toxoplasma antigen during acute toxoplasmosis. Infect. Immun. 63:751.
37. Leite de Moraes, M. D. C., P. Minoprio, M. Dy, M. Dardenne, W. Savino, and M. Hontebeyrie-Joskowicz. 1994. Endogenous IL-10 and IFN-γ production controls thymic cell proliferation in mice acutely infected by Trypanosoma cruzi. Scand. J. Immunol. 39:51.
38. Taylor, K., V. Lutje, and B. Martens. 1996. Nitric oxide synthesis is depressed in Bos indicus cattle infected with Trypanosoma congolense and Trypanosoma vivax and does not mediate T cell suppression. Infect. Immun. 64:4115.
39. Beschin, A., L. Brys, S. Magez, M. Radwanska, and P. De Baetselier. 1998. Trypanosoma brucei infection elicits nitric oxide-dependent and nitric oxide-independent suppressive mechanisms. J. Leukocyte Biol. 63:429.
40. Uzonna, J. E. 1998. Role of cytokines in resistance to African trypanosomes. Doctoral dissertation, University of Saskatchewan, Saskatoon, Canada.
41. Mabott, N. A., I. A. Sutherland, and J. M. Sternberg. 1995. Suppressor macrophages in Trypanosoma brucei infections: nitric oxide is related to both suppressive activity and lifespan in vivo. Parasite Immunol. 17:218.
42. Moore, K. W., A. O'Gara, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin 10. Annu. Rev Immunol 11:165.
43. Willems, F., A. Marchant, J. P. Delville, C. Gerard, A. Delvaux, M. de-Boer, and M. Goldman. 1994. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur. J. Immunol. 24:1007.
44. Reynolds, D. S., W. H. Boom, and A. K. Abbas. 1987. Inhibition of B lymphocyte activation by interferon-γ. J. Immunol. 139:767.
45. Metzger, D. W., R. M. McNutt, J. T. Collins, J. M. Buchanan, V. H. Van-Cleave, and W. A. Dunnick. 1997. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-γ-dependent and -independent mechanisms. Eur. J. Immunol. 27:1958.
46. + T cells suppress growth of Trypanosoma brucei brucei and interferon-γ production in infected rats. Clin. Exp. Immunol. 81:195.
47. Kaushik, R. S., J. E. Uzonna, and H. Tabel. 1997. Effect of different cytokines on the growth of Trypanosoma congolense cultured under axenic conditions. Vet. Parasitol. 70:25.
48. 75Selabeled Trypanosoma brucei in mice. II. Mechanisms in immune animals. Immunology 40:629.
49. Beutler, B., and A. Cerami. 1989. The biology of cachetin/TNF: a primary mediator of the host response. Annu. Rev. Immunol. 7:625.
50. Tachado, S. D., and L. Schofield. 1994. Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1α and TNF-α expression in macrophages by protein tyrosine kinase mediated signal transduction. Biochem. Biophys. Res. Commun. 205:984.
51. Tabel, H., J. R. Gordon, J. Uzonna, and R. Kaushik. 1994. Cytokine cascades in experimental African trypanosomiasis. Cytokine 6:570.
52. + T cells. Annu. Rev. Immunol. 12:635.
53. Uzonna, J. E., R. S. Kaushik, J. R. Gordon, and H. Tabel. Cytokines and antibody responses during Trypanosoma congolense infections in two inbred mouse strains that differ in resistance. Parasite Immunol. In press.
54. - cells in the production of IL-4, IL-10 and IFN-γ and in trypanosome-elicited immunosuppression. J. Immunol. In press.